Top

Published in:

01-12-2024 | Brain Arteriovenous Malformation | Research

Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis

Authors: Basel Musmar, Joanna M. Roy, Hamza Adel Salim, Elias Atallah, Stavropoula I. Tjoumakaris, Michael Reid Gooch, Hekmat Zarzour, Ritam Ghosh, Richard F. Schmidt, Robert H. Rosenwasser, Pascal Jabbour

Published in: Neurosurgical Review | Issue 1/2024

Abstract

Since the first use of embolization for cerebral arteriovenous malformations (AVMs) by Luessenhop and Spence in 1960, this procedure has become a cornerstone in the multimodal treatment approach for brain AVMs. Currently, in the United States, the main embolic agents employed are n-butyl cyanoacrylate (NBCA) and Onyx (Medtronic, Minneapolis, MN). This systematic review and meta-analysis aim to compare these two agents in terms of efficacy and safety. An updated guideline for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was followed. The search strategy involved retrieving articles from PubMed, Scopus, and Web of Science from inception of these databases until June 27th, 2024, using specific search terms. Inclusion criteria were comparative studies of Onyx (Medtronic, Minneapolis, MN) and NBCA, peer-reviewed original studies published in full-text, and studies reporting at least one of the outcomes of interest. Statistical analysis was performed using R software version 4.3.1. After screening 3177 articles, 33 articles were assessed in full-text, and 4 studies were included in the final analysis. These studies included 374 patients, 170 (45.4%) females. There was no significant difference in complication rates between Onyx (Medtronic, Minneapolis, MN) and NBCA (risk ratio [RR]: 0.91; CI: 0.31 to 2.67, p = 0.86) with significant heterogeneity (I²=68%, p = 0.02). Technical success did not differ significantly (RR: 1.38; CI: 0.72 to 2.62, p = 0.33) with significant heterogeneity (I²=73%, p = 0.02). Mortality (RR: 1.5; CI: 0.28 to 8.08, p = 0.64; I²=16%, p = 0.31), morbidity (RR: 1.39; CI: 0.16 to 12.08, p = 0.76; I²=53%, p = 0.14), and blood loss (MD: -0.1; CI: -0.8 to 0.5, p = 0.72; I²=53%, p = 0.15) also showed no significant differences. Both NBCA and Onyx are effective and safe for embolization of cerebral AVMs, with no significant differences in complications, technical success, mortality, morbidity, and blood loss. Further research, particularly randomized controlled trials, is needed to better understand their comparative efficacy and safety.

Available only for authorised users

Luessenhop AJ, Spence WT (1960) Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. J Am Med Assoc 172:1153–1155. https://doi.org/10.1001/jama.1960.63020110001009CrossRefPubMed

Lv X, Zhang Y, Wang J (2020) Systematic review of transcatheter arterial embolization of AVM: indications, bleeding complications, cure rate, and long-term bleeding risk. Neurol India 68(6):1285–1292. https://doi.org/10.4103/0028-3886.304101CrossRefPubMed

Lv X, Liang S (2020) Update Onyx embolization for plexiform arteriovenous malformation: ante-grade drifting technique. Neuroradiol J 33(5):386–392. https://doi.org/10.1177/1971400920940207CrossRefPubMedPubMedCentral

Zhang H, Liang S, Lv X (2021) Radio-clinical grading system for transarterial AVM embolization: Tsinghua AVM grading system. Neurosci Inf 1(3):100021. https://doi.org/10.1016/j.neuri.2021.100021CrossRef

Pierot L, Kadziolka K, Litré F, Rousseaux P (2013) Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery. AJNR Am J Neuroradiol 34(7):1395–1400. https://doi.org/10.3174/ajnr.A3409CrossRefPubMedPubMedCentral

Jayaraman M, Cloft HJ (2009) Embolization of brain arteriovenous malformations for cure: because we could or because we should? AJNR Am J Neuroradiol 30(1):107–108. https://doi.org/10.3174/ajnr.A1394CrossRefPubMedPubMedCentral

Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I (2009) Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30(1):99–106. https://doi.org/10.3174/ajnr.A1314CrossRefPubMedPubMedCentral

Crowley RW, Ducruet AF, McDougall CG, Albuquerque FC (2014) Endovascular advances for brain arteriovenous malformations. Neurosurgery 74(Suppl 1):S74–82. https://doi.org/10.1227/NEU.0000000000000176CrossRefPubMed

Pérez-Higueras A, López RR, Tapia DQ (2005) Endovascular Treatment of Cerebral AVM: our experience with Onyx. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci 11(Suppl 1):141–157. https://doi.org/10.1177/15910199050110S118CrossRef

10.

Mounayer C, Hammami N, Piotin M et al (2007) Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28(3):518–523PubMedPubMedCentral

11.

Letchuman V, Mittal AM, Gupta HR et al (2023) The era of Onyx Embolization: a systematic and Literature Review of Preoperative Embolization before Stereotactic Radiosurgery for the management of cerebral arteriovenous malformations. World Neurosurg 170:90–98. https://doi.org/10.1016/j.wneu.2022.11.058CrossRefPubMed

12.

Vaidya S, Tozer KR, Chen J (2008) An overview of embolic agents. Semin Interv Radiol 25(3):204–215. https://doi.org/10.1055/s-0028-1085930CrossRef

13.

Debrun GM, Aletich VA, Shownkeen H, Ausman J (1997) Glued catheters during Embolisation of Brain AVMs with Acrylic glue. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci 3(1):13–19. https://doi.org/10.1177/159101999700300102CrossRef

14.

Elsenousi A, Aletich VA, Alaraj A (2016) Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerventional Surg 8(3):265–272. https://doi.org/10.1136/neurintsurg-2014-011427CrossRef

15.

Vollherbst DF, Chapot R, Bendszus M, Möhlenbruch MA, Glue (2022) Onyx, Squid or PHIL? Liquid Embolic agents for the embolization of cerebral arteriovenous malformations and Dural Arteriovenous Fistulas. Clin Neuroradiol 32(1):25–38. https://doi.org/10.1007/s00062-021-01066-6CrossRefPubMed

16.

Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R (2002) Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol 21(1):13–17PubMed

17.

Vinters HV, Debrun G, Kaufmann JC, Drake CG (1981) Pathology of arteriovenous malformations embolized with isobutyl-2-cyanoacrylate (bucrylate). Report of two cases. J Neurosurg 55(5):819–825. https://doi.org/10.3171/jns.1981.55.5.0819CrossRefPubMed

18.

Vinters HV, Galil KA, Lundie MJ, Kaufmann JC (1985) The histotoxicity of cyanoacrylates. A selective review. Neuroradiology 27(4):279–291. https://doi.org/10.1007/BF00339559CrossRefPubMed

19.

n-BCA Trail Investigators (2002) N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 23(5):748–755

20.

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral

21.

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210. https://doi.org/10.1186/s13643-016-0384-4CrossRefPubMedPubMedCentral

22.

ROBINS-I tool| Cochrane Methods. Accessed June 30 (2024) https://methods.cochrane.org/robins-i

23.

Robins J, Breslow N, Greenland S (1986) Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics 42(2):311–323CrossRefPubMed

24.

Velat GJ, Reavey-Cantwell JF, Sistrom C et al (2008) Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times. Neurosurgery. 63(1 Suppl 1):ONS73-78; discussion ONS78-80. https://doi.org/10.1227/01.neu.0000335015.83616.12

25.

Behzadi F, Heiferman DM, Wozniak A et al (2022) Comparison of transarterial n-BCA and Onyx embolization of brain arteriovenous malformations: a single-center 18-year retrospective analysis. J Cerebrovasc Endovasc Neurosurg 24(2):144–153. https://doi.org/10.7461/jcen.2022.E2021.12.003CrossRefPubMedPubMedCentral

26.

Loh Y, Duckwiler GR, Onyx T (2010) Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 113(4):733–741. https://doi.org/10.3171/2010.3.JNS09370

27.

Lv X, Wu Z, Li Y, Yang X, Jiang C (2012) Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation. Neurol Res 34(6):552–556. https://doi.org/10.1179/1743132812Y.0000000044CrossRefPubMed

28.

Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ (1993) The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 78(1):60–69. https://doi.org/10.3171/jns.1993.78.1.0060CrossRefPubMed

29.

Gobin YP, Laurent A, Merienne L et al (1996) Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 85(1):19–28. https://doi.org/10.3171/jns.1996.85.1.0019CrossRefPubMed

30.

Blackburn SL, Ashley WW, Rich KM et al (2011) Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg 114(6):1758–1767. https://doi.org/10.3171/2011.1.JNS10571CrossRefPubMed

31.

Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P (2002) Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 144(9):879–887 discussion 888. https://doi.org/10.1007/s00701-002-0978-6CrossRefPubMed

32.

Murayama Y, Viñuela F, Ulhoa A et al (1998) Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43(5):1164–1175. https://doi.org/10.1097/00006123-199811000-00081CrossRefPubMed

33.

Chaloupka JC, Viñuela F, Vinters HV, Robert J (1994) Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol 15(6):1107–1115PubMedPubMedCentral

34.

Wang J, Wu HC, Wang WW et al (2016) Trigeminal Cardiac Reflex caused by Onyx Embolization of Intracranial Dural Arteriovenous Fistula. Turk Neurosurg 26(3):325–330. https://doi.org/10.5137/1019-5149.JTN.8008-13.1CrossRefPubMed

35.

Puri AS, Thiex R, Zarzour H, Rahbar R, Orbach DB (2011) Trigeminocardiac reflex in a child during pre-onyx DMSO injection for juvenile nasopharyngeal angiofibroma embolization. A case report. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci 17(1):13–16. https://doi.org/10.1177/159101991101700103CrossRef

Title: Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis
Authors: Basel Musmar
Joanna M. Roy
Hamza Adel Salim
Elias Atallah
Stavropoula I. Tjoumakaris
Michael Reid Gooch
Hekmat Zarzour
Ritam Ghosh
Richard F. Schmidt
Robert H. Rosenwasser
Pascal Jabbour
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Keyword: Brain Arteriovenous Malformation
Published in: Neurosurgical Review / Issue 1/2024
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI: https://doi.org/10.1007/s10143-024-03119-z

Advantage and challenges in the use of 5-Aminolevulinic acid (5-ALA) in neurosurgery

Glioma
Correspondence

Combating stroke prevention in low and middle income countries

Cerebral Ischemia
Correspondence

Letter to the Editor: “Efficacy of subthalamic deep brain stimulation programming strategies for gait disorders in Parkinson’s disease: A systematic review and meta-analysis”

Deep Brain Stimulation
Correspondence

Minimally invasive keyhole craniotomies for microsurgical clipping of cerebral aneurysms: comparative meta-analysis of the mini-pterional and supraorbital keyhole approaches

Aneurysm
Review

Comparison of blood distribution on initial imaging vs. early CT perfusion for identification of tissues prone to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Subarachnoid Hemorrhage
Correspondence

Zygomatic Anterolateral Temporal Approach for P1/P2 segment complex posterior cerebral aneurysm: a single-center retrospective study

Aneurysm
Research

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Keynote series | Spotlight on menopause

Springer Medicine

Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis

Abstract

Other articles of this Issue 1/2024

Advantage and challenges in the use of 5-Aminolevulinic acid (5-ALA) in neurosurgery

Combating stroke prevention in low and middle income countries

Letter to the Editor: “Efficacy of subthalamic deep brain stimulation programming strategies for gait disorders in Parkinson’s disease: A systematic review and meta-analysis”

Minimally invasive keyhole craniotomies for microsurgical clipping of cerebral aneurysms: comparative meta-analysis of the mini-pterional and supraorbital keyhole approaches

Comparison of blood distribution on initial imaging vs. early CT perfusion for identification of tissues prone to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Zygomatic Anterolateral Temporal Approach for P1/P2 segment complex posterior cerebral aneurysm: a single-center retrospective study

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Please log in to get access to this content